Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma

BACKGROUND: This study aimed to evaluate the effect of stereotactic ablative radiotherapy (SABR) after incomplete transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients. METHODS: The study enrolled 178 HCC patients initially treated with TACE between 2006 and 2011...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Radiat Oncol
Auteurs principaux: Paik, Eun Kyung, Kim, Mi-Sook, Jang, Won Il, Seo, Young Seok, Cho, Chul-Koo, Yoo, Hyung Jun, Han, Chul Ju, Park, Su Cheol, Kim, Sang Bum, Kim, Young Han
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4759954/
https://ncbi.nlm.nih.gov/pubmed/26896371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0597-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires